Breaking News Instant updates and real-time market news.

DOMO

Domo

$27.65

-1.22 (-4.23%)

07:44
07/17/19
07/17
07:44
07/17/19
07:44

Domo set up for second half strength, says Cowen

Cowen analyst J. Derrick Wood met with Domo management and came away encouraged on the pipeline and early traction with the go-to market changes and the new pricing model, which he believes sets the company up for incremental strength in the second half of the year. The analyst sees significant valuation upside if the company can continue to execute well and as a result he sees a compelling risk/reward profile. Wood reiterated his Outperform rating and $52 price target on Domo shares.

DOMO Domo
$27.65

-1.22 (-4.23%)

03/21/19
NEED
03/21/19
NO CHANGE
Target $50
NEED
Buy
Domo price target raised to $50 from $44 at Needham
Needham analyst Jack Andrews raised his price target on Domo to $50 and kept his Buy rating after its investor day event. The analyst says the presentation has made him "incrementally more positive" on the company's large market opportunity, with customers highlighting the "ostensibility of the platform through use cases that span from ETL to custom applications." Andrews states that the company's "unique" platform is well positioned relative to the "future requirements of enterprise analytics without the exorbitant costs of implementation".
04/02/19
FBCO
04/02/19
NO CHANGE
Target $45
FBCO
Outperform
Domo price target raised to $45 from $40 at Credit Suisse
Credit Suisse analyst Brad Zelnick raised his price target for Domo to $45 from $40 after meeting with management. While no incremental information was revealed, the analyst came away with his thesis firmly intact. Domo continues to make strides, with mounting evidence of product-market fit, and improving though still transitioning execution, he contends. Zelnick reiterates an Outperform rating on the shares.
06/07/19
MSCO
06/07/19
NO CHANGE
Target $47
MSCO
Overweight
Domo quarter better than in-line headlines suggest, says Morgan Stanley
Morgan Stanley analyst Sanjit Singh noted that Domo's headline Q1 results largely met guidance and consensus, but he believes the company disappointed investors that were looking for a "beat and raise" report. However, he thinks Domo's quarter looks better "under the hood," as he contends that improving sales productivity, expanding renewal rates, and larger deal sizes are all signs of building enterprise momentum. Singh trimmed his price target on Domo shares to $47 from $52 following the report but keeps an Overweight rating on the shares.
06/11/19
JMPS
06/11/19
NO CHANGE
JMPS
Outperform
JMP says Tableau and Looker deals have 'positive implications' for Domo, Alteryx
JMP Securities analyst Patrick Walravens said this week's announcements of deals for Tableau (DATA) and Looker reminds him of 2007, when three leading analytics companies at the time were acquired over a period of eight months. He also believes the deals have "positive lateral implications" for Domo (DOMO), Alteryx (AYX) and private companies such as Sisense. Walravens have Outperform ratings on both Domo and Alteryx.

TODAY'S FREE FLY STORIES

ASMB

Assembly Biosciences

$9.30

0.3 (3.33%)

05:06
10/16/19
10/16
05:06
10/16/19
05:06
Initiation
Assembly Biosciences initiated  »

Mizuho starts Assembly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 30

    Oct

AVAV

AeroVironment

$57.14

0.02 (0.04%)

05:00
10/16/19
10/16
05:00
10/16/19
05:00
Upgrade
AeroVironment rating change  »

AeroVironment upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSTG

Pure Storage

$17.65

0.2 (1.15%)

04:57
10/16/19
10/16
04:57
10/16/19
04:57
Upgrade
Pure Storage rating change  »

Pure Storage upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 17

    Dec

BOALY

Boral

$0.00

(0.00%)

04:56
10/16/19
10/16
04:56
10/16/19
04:56
Downgrade
Boral rating change  »

Boral downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Wedbush technology analyst to hold an analyst/industry webcast »

Technology Analyst…

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Wedbush technology analyst to hold an analyst/industry webcast »

Technology Analyst…

JCOM

j2 Global

$96.34

0.47 (0.49%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
j2 Global management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 01

    Nov

  • 19

    Nov

AUY

Yamana Gold

$3.19

-0.1 (-3.04%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Yamana Gold management to meet with TD Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 25

    Oct

SCS

Steelcase

$18.15

0.29 (1.62%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Steelcase management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

TRVI

Trevi Therapeutics

$4.00

-0.55 (-12.09%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Trevi Therapeutics management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

CHWY

Chewy

$26.80

1.03 (4.00%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Chewy management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

MREO

Mereo BioPharma

$3.58

0.08 (2.29%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Mereo BioPharma management to meet with SVB Leerink »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
BTIG to hold a forum »

Energy & Shipping…

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
FBN Securities cannabis analysts to hold a breakfast meeting »

Analysts host Chairman…

04:55
10/16/19
10/16
04:55
10/16/19
04:55
General news
Breaking General news story  »

Chicago Federal Reserve…

04:55
10/16/19
10/16
04:55
10/16/19
04:55
General news
Breaking General news story  »

Week of 10/11 MBA…

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Wedbush enterprise software analysts to hold an advisor luncheon »

Enterprise Software…

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
FBN Securities media analyst to hold an analyst/industry conference call »

Media & Entertainment…

NXTC

NextCure

$26.93

-0.175 (-0.65%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
NextCure management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

PIRS

Pieris Pharmaceuticals

$3.22

0.01 (0.31%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Pieris Pharmaceuticals management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 31

    Oct

CKPT

Checkpoint Therapeutics

$2.10

0.08 (3.96%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Checkpoint Therapeutics management to meet with Lake Street »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

TTGT

TechTarget

$22.87

0.47 (2.10%)

, SKHCY

Sonic Healthcare

$0.00

(0.00%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Commvault to hold a conference »

Commvault GO 2019 will be…

TTGT

TechTarget

$22.87

0.47 (2.10%)

SKHCY

Sonic Healthcare

$0.00

(0.00%)

NTAP

NetApp

$53.09

0.88 (1.69%)

HPE

HP Enterprise

$15.15

0.21 (1.41%)

HLF

Herbalife Nutrition

$38.08

-0.67 (-1.73%)

FORR

Forrester

$33.93

1.325 (4.06%)

CSCO

Cisco

$46.37

0.33 (0.72%)

CVLT

Commvault

$45.22

-0.24 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 29

    Oct

  • 29

    Oct

  • 01

    Nov

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

  • 12

    Dec

FLGT

Fulgent Genetics

$11.14

0.09 (0.81%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Fulgent Genetics management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 04

    Nov

ISEE

IVERIC bio

$0.99

-0.0016 (-0.16%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
IVERIC bio management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

TORC

resTORbio

$6.89

-0.09 (-1.29%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
resTORbio management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.